InterCure (INCR) Secures NIS 22M Private Placement for Growth

InterCure (NASDAQ: INCR) (TSX: INCR.U) announced on June 23, 2026, it has secured NIS 22 million (approximately $5.9 million USD) through a private placement financing. The capital infusion is intended to strengthen the company's balance sheet and support its ongoing growth strategy. The financing round saw participation from existing investors, underscoring continued confidence in InterCure's market position. This strategic funding is expected to facilitate the company's expansion plans, particularly in key international markets such as Germany, where InterCure maintains a significant presence in the medical cannabis sector.